Sarepta Therapeutics (SRPT) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

SRPT Sarepta Therapeutics

Watchlist

127.100
+2.090+1.67%

Close Sep 19 16:00 ET

127.100
0.0000.00%

Post 20:02 ET

12.12BMarket Cap169.47P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Implied Volatility Surging for Sarepta Therapeutics (SRPT) Stock Options
Zacks Sep 19 07:35 ET
10 Health Care Stocks With Whale Alerts In Today's Session
BenzingaSep 18 13:35 ET
Express News | Sarepta Therapeutics Inc - Board Now Comprises Nine Directors, Eight Independent
ReutersSep 16 08:31 ET
Sarepta Therapeutics Appoints Deirdre Connelly to Its Board of Directors
BusinesswireSep 16 08:30 ET
High Growth Tech Stocks In The United States You Should Know
Yahoo FinanceSep 13 06:02 ET
BMO Capital Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Maintains Target Price $200
Moomoo NewsSep 11 15:32 ET · Ratings

Comments

Clintzilla

Sep 14 12:52

$Sarepta Therapeutics (SRPT.US)$ if SPY crashes we come back to 85/90 range before 200-300.. if we head back to 150-175 we go to 200 anyway.. this is a phenomenal Company.. know what you hold, be an investor not a penny flipper.. IYKYK

Clintzilla

Sep 14 12:50

$Longeveron (LGVN.US)$ just remember all good things come to those who wait.. if you want to look into the future of this company.. take a look at $Sarepta Therapeutics (SRPT.US)$ Big Pharm can't block stem cells forever

whqqq

Jul 16 20:48

Cramer’s Lightning Round: Don’t sell Match Group

$Fortinet (FTNT.US)$ : “I think Fortinet is not my favorite. Palo Alto is, we own it for the Charitable Trust.”
$Air Products & Chemicals (APD.US)$ : “You really don’t want to be in Air Products, you want to be in Linde. Linde’s a much better run company, and that’s why Air Products isn’t doing as well , and Linde’s doing spectacularly.”
$Sarepta Therapeutics (SRPT.US)$ : “I think Sarepta is a speculative situation where they have great science. ...

Meltyy

Jun 25 07:02

🔔 FDA PDUFA Update…

🔥 3 PDUFA decisions this week! 👇
📌 This week’s PDUFAs:
$Merck & Co (MRK.US)$ : 🤔
⇨ Patritumab deruxtecan
‣ Non-small cell lung carcinoma
‣ PDUFA date: 6/26/24 (BLA)
$Verona Pharma (VRNA.US)$ : 🤔
⇨ Ensifentrine (Nebulized)
‣ Chronic obstructive pulmonary disease
‣ PDUFA date: 6/26/24 (NDA)
$Genmab (GMAB.US)$ : 🤔
⇨ EPKINLY® (Epcoritamab)
‣ Follicular lymphoma
‣ PDUFA date: 6/28/24 (sBLA)
🗓️ Last week’s PDUFAs:
$Merck & Co (MRK.US)$ : Approved 6/17 🎉
⇨ CAPVAXIVE (V116)
‣ Pneumo...

Moomoo Recap US

Jun 21 15:16

Columns S&P 500, Nasdaq Dip as Nvidia is Most-Shorted Among Mag 7 Peers | Wall Street Today

by Luzi Ann Santos | moomoo News
U.S. stock indices retreated as Nvidia gave back some of its recent gains ahead of the quarter-end rebalancing of investors' portfolio that could further drive volatility.
The $S&P 500 Index (.SPX.US)$ slipped 0.2% to 5464.62, while the $Nasdaq Composite Index (.IXIC.US)$ fell 0.2% to 17689.36 . The $Dow Jones Industrial Average (.DJI.US)$ managed to hold on to gains, even as it cl...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

SRPT Sarepta Therapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target